Hematologic Cancer
📧 Sign up to get email alerts when something new happens for Hematologic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil with or without sirolimus to prevent acute graft-versus-host disease …
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT) [Phase 3]
Phase 3 trial completed evaluating a stress management intervention for caregivers of patients undergoing bone marrow transplant.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Physiotherapy in Hematopoietic Stem Cell Transplantation [NA]
This entry reports a clinical trial evaluating physiotherapy in patients undergoing hematopoietic stem cell transplantation. The current sta…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors [Phase 1]
Phase 1 pharmacokinetic study of subcutaneously administered homoharringtonine (omacetaxine mepesuccinate) in patients with advanced solid a…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating decitabine in patients with advanced refractory solid tumors or lymphomas; study status terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-03-09Clinical Trial Update: Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain [NA]
A Mayo Clinic-sponsored clinical trial evaluating opioids with or without olanzapine for moderate to severe cancer pain has been withdrawn.